Company intelligence / Profile preview

Antibac

Asker, Norway

Ownership: Private
Employees: ~18
Development stage: Other

Overview

Antibac is a Norwegian disinfection and professional hygiene brand focused on hand and surface disinfection products used in healthcare and other professional settings. The brand traces its history in Norway back to 1922 and is marketed today by KiiltoClean AS, part of Finland-based Kiiltoclean Oy. Antibac products are commercialized rather than developed as a therapeutic drug pipeline, with offerings centered on alcohol-based disinfectants formulated for activity against bacteria, mycobacteria, enveloped viruses and yeasts. In practice, Antibac is best understood as a healthcare-associated hygiene and infection-prevention brand, not a biotech or pharmaceutical drug developer.

Therapeutic areas: Infectious Diseases
Modalities: Biologic
Industry: Consumable Medical Devices

Beyond the preview

Go deeper on Antibac.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Antibac.

Explore the full profile